GSK3B and hepatocellular carcinoma: In addition, GAL3 has been reported to increase nuclear translocation and activation of β-catenin by promoting glycogen synthase kinase-3beta phosphorylation and reducing its activity [21], and GAL3-mediated β-catenin has been correlated with metastasis of hepatocellular carcinoma [46].